StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron operating margin

Operating margin is operating income as a percentage of revenue.

Geron's operating margin for the twelve months ending Sep 30, 2024 was -705.5%. For fiscal 2023 it was -81832.9%, against -23246.6% the year before. The highest annual figure on record is -1.5% in fiscal 2015.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-81832.9%−58586.3
FY2022Dec 31, 2022-23246.6%−15062.9
FY2021Dec 31, 2021-8183.7%+22216.7
FY2020Dec 31, 2020-30400.4%−14638.4
FY2019Dec 31, 2019-15762.0%−12847.0
FY2018Dec 31, 2018-2914.9%−168.0
FY2017Dec 31, 2017-2746.9%−2249.6
FY2016Dec 31, 2016-497.3%−495.8
FY2015Dec 31, 2015-1.5%+3147.8
FY2014Dec 31, 2014-3149.3%−112.9
FY2013Dec 31, 2013-3036.5%−387.6
FY2012Dec 31, 2012-2648.9%+1293.5
FY2011Dec 31, 2011-3942.4%−822.4
FY2010Dec 31, 2010-3120.0%+949.1
FY2009Dec 31, 2009-4069.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-21.7%+20.4
Q1 FY2026Mar 31, 20260.3%+100.1
Q3 FY2025Sep 30, 2025-29.4%+7831.5
Q2 FY2025Jun 30, 2025-25.4%+18439.7
Q1 FY2025Mar 31, 2025-42.2%+235997.0
Q3 FY2024Sep 30, 2024-99.8%+28931.9
Q2 FY2024Jun 30, 2024-7860.9%+171280.5
Q1 FY2024Mar 31, 2024-18465.1%+172449.2
Q4 FY2023Dec 31, 2023-236039.1%−195310.0
Q3 FY2023Sep 30, 2023-29031.7%−15581.2
Q2 FY2023Jun 30, 2023-179141.4%−140818.1
Q1 FY2023Mar 31, 2023-190914.3%−167601.3
Q4 FY2022Dec 31, 2022-40729.1%−37750.1
Q3 FY2022Sep 30, 2022-13450.5%+10103.6
Q2 FY2022Jun 30, 2022-38323.3%−11324.2
Q1 FY2022Mar 31, 2022-23313.0%−2543.7
Q4 FY2021Dec 31, 2021-2979.0%+43553.0
Q3 FY2021Sep 30, 2021-23554.1%−5021.7
Q2 FY2021Jun 30, 2021-26999.1%+11982.3
Q1 FY2021Mar 31, 2021-20769.3%+11673.0
Q4 FY2020Dec 31, 2020-46532.0%−28983.5
Q3 FY2020Sep 30, 2020-18532.4%−6340.0
Q2 FY2020Jun 30, 2020-38981.4%−23908.1
Q1 FY2020Mar 31, 2020-32442.3%−12616.0
Q4 FY2019Dec 31, 2019-17548.5%−14991.5
Q3 FY2019Sep 30, 2019-12192.4%−8068.1
Q2 FY2019Jun 30, 2019-15073.3%−11591.5
Q1 FY2019Mar 31, 2019-19826.3%−17487.6
Q4 FY2018Dec 31, 2018-2557.1%+1519.4
Q3 FY2018Sep 30, 2018-4124.2%+319.9
Q2 FY2018Jun 30, 2018-3481.7%+386.7
Q1 FY2018Mar 31, 2018-2338.7%−943.1
Q4 FY2017Dec 31, 2017-4076.4%+5265.0
Q3 FY2017Sep 30, 2017-4444.2%−4368.3
Q2 FY2017Jun 30, 2017-3868.4%–
Q1 FY2017Mar 31, 2017-1395.5%–
Q4 FY2016Dec 31, 2016-9341.5%–
Q3 FY2016Sep 30, 2016-75.9%–

More Geron figures

See a number that looks wrong?